Balchem: Q2 Earnings Insights


Shares of Balchem BCPC remained unaffected after the company reported Q2 results.

Quarterly Results

Earnings per share were up 9.41% over the past year to $0.93, which beat the estimate of $0.88.

Revenue of $202,365,000 higher by 16.73% from the same period last year, which beat the estimate of $185,440,000.


Earnings guidance hasn't been issued by the company for now.

Balchem hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: Jul 30, 2021

Time: 11:00 AM

ET Webcast URL:

Recent Stock Performance

52-week high: $134.80

52-week low: $92.60

Price action over last quarter: Up 2.90%

Company Profile

Balchem manufactures ingredients, nutrients, and chemicals for a wide variety of industries, including human nutrition, animal nutrition, and oil and gas. The company offers a wide variety of product lines, with some highly customized and others commodity-oriented. After the 2014 acquisition of SensoryEffects, the human nutrition and health segment now generates the largest share of companywide revenue and profits.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!